SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-017779
Filing Date
2023-11-06
Accepted
2023-11-06 16:35:59
Documents
97
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q chrs-20230930x10q.htm   iXBRL 10-Q 2868447
2 EX-10.1 chrs-20230930xex10d1.htm EX-10.1 461761
3 EX-10.2 chrs-20230930xex10d2.htm EX-10.2 21878
4 EX-31.1 chrs-20230930xex31d1.htm EX-31.1 14074
5 EX-31.2 chrs-20230930xex31d2.htm EX-31.2 14970
6 EX-32.1 chrs-20230930xex32d1.htm EX-32.1 12078
  Complete submission text file 0001558370-23-017779.txt   12198368

Data Files

Seq Description Document Type Size
7 EX-101.SCH chrs-20230930.xsd EX-101.SCH 87651
8 EX-101.CAL chrs-20230930_cal.xml EX-101.CAL 86583
9 EX-101.DEF chrs-20230930_def.xml EX-101.DEF 369471
10 EX-101.LAB chrs-20230930_lab.xml EX-101.LAB 658598
11 EX-101.PRE chrs-20230930_pre.xml EX-101.PRE 539146
91 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20230930x10q_htm.xml XML 2073557
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36721 | Film No.: 231380439
SIC: 2836 Biological Products, (No Diagnostic Substances)